CN Patent

CN114127086B — 氘代肽酰胺类化合物及其制备方法和在医药上的用途

Assigned to Haisco Pharmaceutical Group Co Ltd · Expires 2023-10-20 · 3y expired

What this patent protects

本发明涉及一种通式(I)所示的化合物或其立体异构体、水合物、代谢产物、溶剂化物、药学上可接受的盐或共晶及其组合物、制备方法和在医药上的用途，通式(I)如下所示，各取代基的定义与说明书中一致。

USPTO Abstract

本发明涉及一种通式(I)所示的化合物或其立体异构体、水合物、代谢产物、溶剂化物、药学上可接受的盐或共晶及其组合物、制备方法和在医药上的用途，通式(I)如下所示，各取代基的定义与说明书中一致。

Drugs covered by this patent

Patent Metadata

Patent number
CN114127086B
Jurisdiction
CN
Classification
—
Expires
2023-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Haisco Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.